Combined intracavitary thermotherapy with iron oxide nanoparticles and radiotherapy as local treatment modality in recurrent glioblastoma patients

被引:0
|
作者
Oliver Grauer
Mohammed Jaber
Katharina Hess
Matthias Weckesser
Wolfram Schwindt
Stephan Maring
Johannes Wölfer
Walter Stummer
机构
[1] University Hospital of Münster,Department of Neurology
[2] University Hospital of Münster,Department of Neurosurgery
[3] University Hospital of Münster,Institute of Neuropathology
[4] University Hospital of Münster,Department of Nuclear Medicine
[5] University Hospital of Münster,Institute of Radiology
[6] University Hospital of Münster,Department of Radiation Oncology
[7] Hufeland Klinikum GmbH,Competence Center for Neurosurgery
来源
Journal of Neuro-Oncology | 2019年 / 141卷
关键词
Superparamagnetic iron oxide nanoparticles; Thermotherapy; HSP70; Caspase-3; PD-L1;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:83 / 94
页数:11
相关论文
共 50 条
  • [41] Feasibility and phase II study of combined modality treatment with accelerated radiotherapy and chemotherapy in patients with locally advanced inoperable carcinoma of the pancreas
    Berns, T
    Prott, FJ
    Preusser, P
    Schonekas, K
    Senninger, N
    Willich, N
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1251 - 1251
  • [42] Improved survival in patients with Stage III-IV head and neck cancer treated with radiotherapy as primary local treatment modality
    Rusthoven, Kyle E.
    Raben, David
    Chen, Changhu
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (02): : 343 - 350
  • [43] Mono- vs. multi-core magnetic iron oxide nanoparticles as dual agents for imaging and treatment of glioblastoma
    Hemery, Gauvin
    Genevois, Coralie
    Couillaud, Franck
    Lacomme, Sabrina
    Gontier, Etienne
    Lecommandoux, Sebastien
    Garanger, Elisabeth
    Sandre, Olivier
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [44] Important factors for a combined neurovascular team to consider in selecting a treatment modality for patients with previously clipped residual and recurrent intracranial aneurysms
    Hoh, BL
    Carter, BS
    Putman, CM
    Ogilvy, CS
    NEUROSURGERY, 2003, 52 (04) : 732 - 738
  • [45] A Comparison of Oncologic Outcomes and Toxicity with Combined Modality Therapy vs. Carbon Ion Radiotherapy for Locally Recurrent Rectal Cancer in Previously Irradiated Patients
    Jeans, E.
    Qualls, K. W.
    Cunningham, D.
    Takiyama, H.
    Waddle, M. R.
    Yamada, S.
    Jethwa, K. R.
    Harmsen, W. S.
    Hubbard, J. M.
    Dozois, E. J.
    Mathis, K. L.
    Tsuji, H.
    Merrell, K. W.
    Hallemeier, C. L.
    Mahajan, A.
    Foote, R. L.
    Haddock, M. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E48 - E49
  • [46] Treatment outcomes of hypofractionated radiotherapy combined with temozolomide followed by bevacizumab salvage therapy in glioblastoma patients aged > 75 years
    Matsuda, Ken-ichiro
    Sakurada, Kaori
    Nemoto, Kenji
    Kayama, Takamasa
    Sonoda, Yukihiko
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (05) : 820 - 825
  • [47] Phase II trial of combined temozolomide and pegylated liposomal doxorubicin in the treatment of patients with glioblastoma multiforme following concurrent radiotherapy and chemotherapy
    Ananda, S.
    Nowak, A. K.
    Cher, L.
    Dowling, A. J.
    Brown, C.
    Simes, R. J.
    Rosenthal, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [48] Radiotherapy-Controllable Chemotherapy from Reactive Oxygen Species-Responsive Polymeric Nanoparticles for Effective Local Dual Modality Treatment of Malignant Tumors
    Liu, Te-I
    Yang, Ying-Chieh
    Chiang, Wen-Hsuan
    Hung, Chun-Kai
    Tsai, Yuan-Chung
    Chiang, Chi-Shiun
    Lo, Chun-Liang
    Chiu, Hsin-Cheng
    BIOMACROMOLECULES, 2018, 19 (09) : 3825 - 3839
  • [49] TOXICITY OF COMBINED BEVACIZUMAB-LOMUSTINE TREATMENT IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM): REPORT FROM A RANDOMIZED PHASE II STUDY
    van den Bent, Martin
    Taal, Walter
    Sleijfer, Stefan
    van Heuvel, Irene
    SillevisSmitt, Peter A.
    Bromberg, Jacoline E.
    Vernhout, Irene
    NEURO-ONCOLOGY, 2010, 12 : 42 - 42
  • [50] COMBINED MODALITY TREATMENT OF LOCAL REGIONALLY ADVANCED BREAST-CANCER PATIENTS - 5 TO 10 YEAR FOLLOW-UP
    LOPRINZI, CL
    RASMUSSEN, PW
    TORMEY, DC
    CARBONE, PP
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1989, 12 (03): : 208 - 212